*Division of Head and Neck, Ophthalmology Unit, IRCSS Ospedale San Raffaele, Milan, Italy;

†School of Medicine, Vita-Salute San Raffaele University, Milan, Italy;

‡Department of Ophthalmology, Koç University School of Medicine, Istanbul, Turkey;

§Department of Ophthalmology, Centre Hospitalier Intercommunal de Créteil, Université Paris Est, Créteil, France;

¶UniCamillus University, Rome, Italy; and

**IRCCS - Fondazione Bietti, Rome, Italy.

Reprint requests: Giuseppe Querques, MD, PhD, Department of Ophthalmology, University Vita-Salute, IRCCS San Raffaele, Milan, Italy; e-mail: [email protected]

R. Sacconi is consultant for Allergan Inc, Bayer Shering-Pharma, Medivis, Novartis, and Zeiss. E. H. Souied is consultant for Allergan, Novarti, Bayer, Roche. F. Bandello is consultant for Alcon, Alimera Sciences, Allergan Inc, Farmila-Thea, Bayer Shering-Pharma, Baush and Lomb, Genentech, Hoffmann-La-Roche, Novagali Pharma, Novartis, Sanofi-Aventis, Thrombogenics, and Zeiss. G. Querques is consultant for Alimera Sciences, Allergan Inc, Amgen, Bayer Shering-Pharma, Heidelberg, KBH, LEH Pharma, Lumithera, Novartis, Sandoz, Sifi, Sooft-Fidea, and Zeiss. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

A. Servillo and C. Kesim equally contributed to the manuscript.